Healthcare Market Research Reports & Industry Analysis

Publications found: 71,834
Sort by:

Pancreatic Endocrine Tumor - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pancreatic Endocrine Tumor' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 161 pages

Paroxysmal Nocturnal Hemoglobinuria - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Paroxysmal Nocturnal Hemoglobinuria' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

March 2018 166 pages

Partial Seizure - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Partial Seizure' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 216 pages

Peanut Allergy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Peanut Allergy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 206 pages

Peptic Ulcers - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Peptic Ulcers' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 160 pages

Periodontal Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Periodontal Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease overview, classifications, stages ...

March 2018 176 pages

Peripheral Arterial Disease (Pad)/ Pulmonary Vascular Disease (Pvd) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)' - Market Access, Reimbursement Outlook, Competitive Landscapet, ... and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, reimbursement scenario, ...

March 2018 217 pages

Peripheral Neuropathic Pain - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Peripheral Neuropathic Pain' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

March 2018 167 pages

Phenylketonuria (Pku) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Phenylketonuria (PKU)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 212 pages

Plague - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Plague' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 188 pages

Plaque Psoriasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Plaque Psoriasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 191 pages

Pleural Effusion - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pleural Effusion' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 174 pages

Polycystic Kidney Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

... 'Polycystic Kidney Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... biomarkers. Key patient segment and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual ...

March 2018 181 pages

Polycythemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Polycythemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 209 pages

Polymyositis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Polymyositis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 176 pages

Pompe Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pompe Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease overview, classifications, stages ...

March 2018 203 pages

Porphyria - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Porphyria' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 151 pages

Post Menopausal Osteoporosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Post Menopausal Osteoporosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

March 2018 176 pages

Postherpetic Neuralgia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Postherpetic Neuralgia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 200 pages

Postmenopausal Vaginal Atrophy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Postmenopausal Vaginal Atrophy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

March 2018 181 pages

Post-Traumatic Stress Disorder (Ptsd) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Post-Traumatic Stress Disorder (PTSD)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 219 pages

Premature Labor (Tocolysis) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Premature Labor (Tocolysis)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

March 2018 214 pages

Primary Biliary Cirrhosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Primary Biliary Cirrhosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 212 pages

Primary Immune Deficiency (Pid) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Primary Immune Deficiency (PID)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 155 pages

Primary Progressive Multiple Sclerosis (Ppms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Primary Progressive Multiple Sclerosis (PPMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 196 pages

Pruritus - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pruritus' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 192 pages

Psoriatic Arthritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Psoriatic Arthritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 189 pages

Pulmonary Embolism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pulmonary Embolism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 214 pages

Pyelonephritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pyelonephritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 146 pages

Radiation Toxicity - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Radiation Toxicity' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 192 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Recurrent Head And Neck Cancer Squamous Cell Carcinoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, ...

March 2018 213 pages

Relapsed Chronic Lymphocytic Leukemia (Cll) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Relapsed Chronic Lymphocytic Leukemia (CLL)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 159 pages

Relapsing Multiple Sclerosis (Rms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Relapsing Multiple Sclerosis (RMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 199 pages

Restless Legs Syndrome - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Restless Legs Syndrome' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 156 pages

Retinal Vein Occlusion - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Retinal Vein Occlusion' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 155 pages

Rhino-Conjunctivitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Rhino-Conjunctivitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 219 pages

Rosacea - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Rosacea' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 168 pages

Sarcoidosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Sarcoidosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 169 pages

Schistosomiasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Schistosomiasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 164 pages

Seasonal Allergic Rhinitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Seasonal Allergic Rhinitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 204 pages

Secondary Hyperparathyroidism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Secondary Hyperparathyroidism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 199 pages

Secondary Progressive Multiple Sclerosis (Spms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Secondary Progressive Multiple Sclerosis (SPMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 145 pages

Sedation - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Sedation' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 165 pages

Global Tissue Engineering Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... the Report: This report focuses on the Tissue Engineering in global market, especially in North America, Europe, Asia ... display the global Tissue Engineering market. Chapter 1, to describe Tissue Engineering Introduction, product scope, market overview, market opportunities, market risk, market driving force; ...

March 2018 100 pages

Europe Acinetobacter Infections Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 4,480.00

... to deeply display the Europe Acinetobacter Infections Treatment market. Chapter 1, to describe Acinetobacter Infections Treatment Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

March 2018 101 pages

Europe Tyrosine Kinase JAK Inhibitors Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 4,480.00

... of the Report: This report focuses on the Tyrosine Kinase JAK Inhibitors in Europe market, especially in Germany, UK, France, Russia, ... 17 Chapters to deeply display the Europe Tyrosine Kinase JAK Inhibitors market. Chapter 1, to describe Tyrosine Kinase JAK Inhibitors Introduction, product type and application, ...

March 2018 101 pages

Europe Venous Stents Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 4,480.00

... Europe Venous Stents market. Chapter 1, to describe Venous Stents Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Venous Stents ...

March 2018 103 pages

Global Brachytherapy Therapy Market 2018-2024

US$ 2,750.00

Global Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves ...

March 2018 99 pages

North America and Europe Endoscopic Cold Light Source Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... the Report: This report focuses on the Endoscopic Cold Light Source in North America and Europe market, especially in United States, United Kingdom ... Chapters to deeply display the North America and Europe Endoscopic Cold Light Source market. Chapter 1, to describe Endoscopic Cold Light Source Introduction, ...

March 2018 103 pages

North America and Europe Eosinophilic Esophagitis Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... the Report: This report focuses on the Eosinophilic Esophagitis Drug in North America and Europe market, especially in United States, United Kingdom ... to deeply display the North America and Europe Eosinophilic Esophagitis Drug market. Chapter 1, to describe Eosinophilic Esophagitis Drug Introduction, product ...

March 2018 101 pages

Filters

Search

Categories

190
210
1,202
34
238
217
157
143
64,289
1,332
1,270
2,367
185

Publishers

179
1
1,465
34
239
366
389
103
148
348
3
202
3
6
1,620
487
80
123
208
112
25
1,049
378
23
40
68
510
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,530
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
384
8
3
18
58
907
6
89
12
24
15
1,285
227
128
386
3
74
10
119
226
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
797
497
2
2
2
118
197
102
54
23
708
26
135
530
177
646
66,760

Price

—

Date

—

Pages

—

Offers

1
280
1
1